ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 126 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $12,380,000 | +15.9% | 8,479,445 | +12.7% | 0.02% | 0.0% |
| Q4 2016 | $10,682,000 | -12.0% | 7,522,255 | +8.4% | 0.02% | -19.0% |
| Q3 2016 | $12,139,000 | +26.7% | 6,936,496 | +23.8% | 0.02% | +16.7% |
| Q2 2016 | $9,578,000 | +9.9% | 5,601,355 | +26.6% | 0.02% | +5.9% |
| Q1 2016 | $8,715,000 | +46.6% | 4,423,855 | +41.4% | 0.02% | +30.8% |
| Q4 2015 | $5,945,000 | +48.1% | 3,129,200 | +48.9% | 0.01% | +30.0% |
| Q3 2015 | $4,015,000 | -48.1% | 2,102,200 | +26.1% | 0.01% | -44.4% |
| Q2 2015 | $7,734,000 | +91.4% | 1,666,800 | +80.2% | 0.02% | +100.0% |
| Q1 2015 | $4,041,000 | +405.1% | 924,800 | +301.2% | 0.01% | +350.0% |
| Q4 2014 | $800,000 | -75.3% | 230,500 | -70.2% | 0.00% | -77.8% |
| Q3 2014 | $3,240,000 | +864.3% | 773,155 | +1248.0% | 0.01% | +800.0% |
| Q2 2014 | $336,000 | – | 57,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 10,500,000 | $18,375,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 1,637,891 | $2,866,309,000 | 0.74% |
| Virtus ETF Advisers LLC | 317,632 | $556,000 | 0.27% |
| TFS CAPITAL LLC | 609,929 | $1,067,000 | 0.26% |
| GLOBEFLEX CAPITAL L P | 571,940 | $1,001,000 | 0.25% |
| Lyons Wealth Management, LLC. | 42,408 | $74,000 | 0.10% |
| Jacobi Capital Management LLC | 35,000 | $64,000 | 0.03% |
| AFFINITY WEALTH MANAGEMENT LLC | 24,538 | $43,000 | 0.03% |
| Renaissance Technologies | 6,936,496 | $12,139,000 | 0.02% |
| A.R.T. Advisors, LLC | 26,500 | $46,000 | 0.02% |